Pekao Towarzystwo Funduszy Inwestycyjnych SA’s Gilead Sciences GILD Stock Holding History

Pekao Towarzystwo Funduszy Inwestycyjnych SA’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	+2,765	New	+$364K	0.22%	67

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pekao Towarzystwo Funduszy Inwestycyjnych SA's GILD Position: Q2 2026 in Review

Pekao Towarzystwo Funduszy Inwestycyjnych SA opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,765 shares worth $349K. The stake represents 0.22% of the portfolio and ranks #67 among its holdings.

2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Pekao Towarzystwo Funduszy Inwestycyjnych SA held 2,765 shares of Gilead Sciences worth $349K as of Q2 2026.
Gilead Sciences was a new Pekao Towarzystwo Funduszy Inwestycyjnych SA position in Q2 2026.
Gilead Sciences made up 0.22% of Pekao Towarzystwo Funduszy Inwestycyjnych SA's portfolio in Q2 2026, its #67 holding.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pekao Towarzystwo Funduszy Inwestycyjnych SA's 13F filing for Q2 2026, filed 23 Jul 2026.